97 related articles for article (PubMed ID: 12934314)
1. [Methods of hormone replacement therapy in hypertensive women].
Andreev AN; Izmozherova NV; Popov AA; Stepanova LV
Klin Med (Mosk); 2003; 81(7):56-9. PubMed ID: 12934314
[TBL] [Abstract][Full Text] [Related]
2. [Specific aspects of the course of bronchial asthma therapy in perimenopausal period].
Paleev NP; Shabalin VN; Chereĭskaia NK; Iurina TM; Slivets ON; Shapovalenko SA
Klin Med (Mosk); 1999; 77(5):17-20. PubMed ID: 10394780
[TBL] [Abstract][Full Text] [Related]
3. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
4. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
[TBL] [Abstract][Full Text] [Related]
5. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension.
Czarnecka D; Kawecka-Jaszcz K; Olszanecka A; Dembińska-Kieć A; Malczewska-Malec M; Zdzienicka A; Guevara I
Med Sci Monit; 2004 Feb; 10(2):CR55-61. PubMed ID: 14737044
[TBL] [Abstract][Full Text] [Related]
6. [Question of a Colleague. Can I still give advice to my wife about hormone replacement?].
Seifert-Klauss V
MMW Fortschr Med; 2002 Oct; 144(44):18. PubMed ID: 12494594
[No Abstract] [Full Text] [Related]
7. [Arterial hypertension in menopausal women: Clinical, functional, and pharmaco-economical aspects].
Gel'tser BI; Kotel'nikov VN; Khludeeva TA
Klin Med (Mosk); 2003; 81(10):19-24. PubMed ID: 14664167
[TBL] [Abstract][Full Text] [Related]
8. [Use captopril and estradiol-medroxyprogesterone in premenopausal hypertensive patients].
Zayas Jaime FJ; Ortega Clavero H; Baños Baños A; Lazo Javalera F
Ginecol Obstet Mex; 2000 Dec; 68():469-75. PubMed ID: 11195960
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.
Peled Y; Perri T; Pardo Y; Kaplan B
Menopause; 2007; 14(3 Pt 1):550-4. PubMed ID: 17224852
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure in middle-aged women: are androgens involved? A population-based study of Swedish women: the Women's Health in the Lund Area study.
Khatibi A; Agardh CD; Nyberg P; Lidfeldt J; Samsioe G
J Hypertens; 2007 Oct; 25(10):2044-50. PubMed ID: 17885546
[TBL] [Abstract][Full Text] [Related]
11. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
de Carvalho MN; Nobre F; Mendes MC; Dos Reis RM; Ferriani RA; Silva de Sá MF
Blood Press Monit; 2008 Oct; 13(5):277-83. PubMed ID: 18799953
[TBL] [Abstract][Full Text] [Related]
12. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
Spritzer PM; Vitola D; Vilodre LC; Wender MC; Reis FM; Ruschel S; Castro I
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):267-73. PubMed ID: 12951632
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
Karalis I; Beevers G; Beevers M; Lip G
Blood Press; 2005; 14(1):38-44. PubMed ID: 15823946
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.
White WB; Pitt B; Preston RA; Hanes V
Circulation; 2005 Sep; 112(13):1979-84. PubMed ID: 16186434
[TBL] [Abstract][Full Text] [Related]
15. [Replacement hormonal therapy: effects on ECG parameters in postmenopausal women].
Zatikian EP; Smetnik VP; Klimenchenko NI
Ter Arkh; 1998; 70(10):33-7. PubMed ID: 9864801
[TBL] [Abstract][Full Text] [Related]
16. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
18. High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
Blumenfeld Z; Boulman N; Leiba R; Siegler E; Shachar S; Linn R; Levy Y
Scand J Clin Lab Invest; 2007; 67(3):257-63. PubMed ID: 17454839
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
[TBL] [Abstract][Full Text] [Related]
20. Effect of estradiol valerate and levonorgestrel on vaginal health.
Manonai J; Chittacharoen A; Theppisai U
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
